CM082 plus JS001
Sponsors
AnewPharma
Conditions
Mucosal MelanomaNon-small Cell Lung CancerSmall Cell Lung Cancer
Phase 2
Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.
NCT03602547
Start: 2018-07-31End: 2020-06-30Target: 40Updated: 2019-07-05
CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
NCT03848611
Start: 2019-04-02End: 2021-09-30Target: 20Updated: 2020-07-09
CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
NCT03904719
Start: 2019-09-18End: 2021-12-31Target: 30Updated: 2020-07-09